Skip to content

An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients

An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients. A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03722264
Enrollment
12
Registered
2018-10-26
Start date
2017-11-16
Completion date
2019-04-12
Last updated
2020-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cavities of Teeth

Brief summary

Fluoride is very effective in preventing dental decay (cavities) when applied in the form of a varnish on tooth surfaces. The purpose of this study is to verify if fluoride-releasing primer (OpalSeal) offers more protection against early dental decay (cavity) compared to conventional primer (Transbond XT) during treatment with braces.

Detailed description

Primers are a type of 'glue' routinely used in orthodontics to attach brackets (metallic components) to the teeth. OpalSeal is a fluoride-releasing primer that has the potential to reduce cavities in patients receiving braces. Orthodontic patients are at particular risk of developing two types of early carious lesions (decay): 1. Around the brackets called White Spot Lesions and 2. Along the sides of the teeth after slenderization procedure called inter-proximal reduction (IPR). Our research questions are: 1. Can OpalSeal offer protection against white spot lesions (WSL) around the brackets? 2. Can OpalSeal offer protection against decay on the sides of teeth following IPR?

Interventions

DEVICEOpalSeal

OpalSeal is a fluoride releasing orthodontic primer that is FDA approved for use during bonding of orthodontic brackets

DEVICETransbondXT

Transbond is a primer used to bond orthodontic brackets that does not contain fluoride

Sponsors

Virginia Commonwealth University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Opalseal and TransbondXT are identical in color, consistency and application allowing random assignments as well as patient blinding. The outcomes assessor will also be blinded to the groups assignments.

Intervention model description

Participants have at least two teeth planned for extraction on either side of the mouth. The study will use a split-mouth design with random assignments for intervention (OpalSeal) on one tooth.

Eligibility

Sex/Gender
ALL
Age
10 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients age 10 and older seeking treatment at the VCU Orthodontics Clinic who require extraction of at least 2 teeth for orthodontic purposes * Such teeth should be free of any developmental defects

Exclusion criteria

* Patients under 10 years of age * Patients with defective teeth * Those who cannot provide consent/assent OR not able to follow research protocols * Protected population (prisoners)

Design outcomes

Primary

MeasureTime frameDescription
Loss of Mineral Density in the EnamelTime from initial bonding to extraction (max 90 days)Teeth will be subjected to microCT to assess the extent of demineralization. Loss of mineral density will be measured as depth of lesions

Secondary

MeasureTime frameDescription
Surface Topography and HardnessTime from initial bonding to extraction (max 90 days)Scanning electron microscopy and atomic force microscopy will be used to evaluate the protective effect of OpalSeal
Retention of OpalSealTime from initial bonding to extraction (max 90 days)The protective effects of OpalSeal is subject to its retention at the site of application. Since OpalSeal fluoresces under black light, its retention will be evaluated

Countries

United States

Participant flow

Recruitment details

12 participants were enrolled with all participants receiving each treatment

Participants by arm

ArmCount
Bilateral Treatment With OpalSeal and Transbond XT
Experimental: OpalSeal OpalSeal will be applied to the buccal surfaces of to-be-extracted teeth on one side of the mouth which will be determined randomly for each participant during bonding of orthodontic brackets, or to the proximal surfaces following IPR in accordance to manufacturer instructions. Since OpalSeal has fluoride releasing capability, this would be experimental arm. Placebo Comparator: Transbond XT TransbondXT will be applied to the buccal surfaces of to-be-extracted teeth on the other side of the mouth which will be determined based on which side received OpalSeal for each participant during bonding of orthodontic brackets, or to the proximal surfaces following IPR in accordance to manufacturer instructions. Transbond XT does not have fluoride and hence would be considered as a placebo.
9
Total9

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyPhysician Decision3

Baseline characteristics

CharacteristicBilateral Treatment With OpalSeal and Transbond XT
Age, CustomizedNA Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
9 participants
Sex/Gender, Customized
Sex not measured
9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Loss of Mineral Density in the Enamel

Teeth will be subjected to microCT to assess the extent of demineralization. Loss of mineral density will be measured as depth of lesions

Time frame: Time from initial bonding to extraction (max 90 days)

Population: 9 teeth in each group were available for analysis

ArmMeasureValue (MEAN)
OpalSealLoss of Mineral Density in the Enamel70.8 microns
Transbond XTLoss of Mineral Density in the Enamel77.4 microns
Secondary

Retention of OpalSeal

The protective effects of OpalSeal is subject to its retention at the site of application. Since OpalSeal fluoresces under black light, its retention will be evaluated

Time frame: Time from initial bonding to extraction (max 90 days)

Population: TransbondXT retention cannot be assessed so no control teeth were analyzed. Only 5 teeth on which OpalSeal was applied were analyzed

ArmMeasureValue (MEDIAN)
OpalSealRetention of OpalSeal28.1 percent coverage
Secondary

Surface Topography and Hardness

Scanning electron microscopy and atomic force microscopy will be used to evaluate the protective effect of OpalSeal

Time frame: Time from initial bonding to extraction (max 90 days)

Population: Data could not be collected for this variable.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026